Drugs / PIMAGEDINE

Trials 4

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT02099981 Jul 2016 → Dec 2017 diabetic retinopathy University of Minnesota Completed No outcome recorded
Phase 1 NCT00184990 Jan → Sep 2005 — Radboud University Medical Center Completed No outcome recorded
Phase not applicable2 trials
— NCT00180635 Oct 2003 → Jul 2006 chronic obstructive pulmonary disease Imperial College London Completed No outcome recorded
— NCT00159380 Sep 2003 → Mar 2005 asthma Imperial College London Completed No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as PIMAGEDINE ChEMBL registry synonym — accepted as the source's own label CHEMBL225304 ↗
Known as Aminoguanidine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02099981 ↗
3

NCT00180635 ↗

NCT00159380 ↗

NCT00184990 ↗

Known as Aminoguanidine hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL225304 ↗
Known as Aminoguanidine hydrochloride ChEMBL registry synonym — accepted as the source's own label CHEMBL225304 ↗
Known as GER-11 ChEMBL registry synonym — accepted as the source's own label CHEMBL225304 ↗
Known as NSC-760398 ChEMBL registry synonym — accepted as the source's own label CHEMBL225304 ↗
Known as Pimagedina ChEMBL registry synonym — accepted as the source's own label CHEMBL225304 ↗
Known as Pimagedine hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL225304 ↗
Known as PIMAGEDINE HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL225304 ↗
Action Inhibit “a relatively selective iNOS inhibitor, aminoguanidine” NCT00159380 ↗
Modality Small molecule — CHEMBL225304 ↗
Route Inhaled “aminoguanidine, by nebulization” NCT00159380 ↗